| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d8d30805708f0d2affd52c695145421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2277b4be6a5c66951adcfc453ace80e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5743 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2017-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_790563380c890f7363e2ac1a65f2480b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e93fa49874cd8f5e7c1bffe2417c0849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_715b78abd59de8d3bc7022ac515ae685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f4ebbc8014d338bc56e7eaf25d170fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74027c14424b3445141d822c6579d8f3 |
| publicationDate |
2020-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3757223-A1 |
| titleOfInvention |
Method for predicting the response of melanoma patients to a medicament |
| abstract |
The present invention relates to a method for determining or predicting the response of a patient diagnosed with melanoma to targeted pharmacotherapy. The present invention also aims to provide methods and devices for predicting the response of patients diagnosed with melanoma to specific medicaments. More specifically, the present invention provides methods which measure kinase and/or phosphatase activity by studying phosphorylation levels and profiles and inhibitions thereof by drugs in samples, preferably blood samples, of said patients. |
| priorityDate |
2016-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |